404
+1-313-307-4176
Bovine Based Collagen For Biomedical Applications Market Report
Bovine-Based Collagen for Biomedical Applications Market Size, Share, Trend, Forecast, & Industry Analysis: 2021-2026
Bovine-Based Collagen for Biomedical Applications Market, By Application (Bone Graft Substitutes, Cartilage Repairs, Collagen-based Scaffolds, Hemostats, Skin Substitutes, Wound dressings), By End-Use (Hospitals, Ambulatory Surgical Centers), and Region - COVID-19 Impact Analysis and Forecast to 2026.
Collagen is a protein, which is largely found in bones, connective tissues, and cartilages of mammals. It plays a key role in skin firming, tissue regeneration and development, and skin elasticity maintenance. Collagen is mainly extracted from chickens, bovine, and marine animals, among others. Bovine collagen is the type of protein extracted from the bones and cartilages of cows.
The Bovine-Based Collagen for Biomedical Applications market is projected to grow from USD 685.3 million in 2020 to USD 1,184.9 million by 2026 at a CAGR of over 9.8% during the forecast period.
|
Bovine-Based Collagen for Biomedical Applications Market - Research Scope |
|
|---|---|
|
Base Year of Study |
2020 |
|
Trend Period |
2015-2019 |
|
Forecast Period |
2021-2026 |
|
Market Size in 2020 |
USD 685.3 million |
|
Market Size in 2026 |
USD 1,184.9 million |
|
Market Growth (2021-2026) |
9.8% CAGR |
The rapidly increasing geriatric population and a growing number of accidents are likely to boost the product demand. Also, an increasing number of patients with medical conditions such as osteoporosis and arthritis further augments the market growth. Moreover, a surge in the demand for orthopedic surgeries, dental surgeries, and cosmetic surgeries for tissue healing and regeneration will be some other factor bolstering the industry's growth in the coming years.
The COVID-19 pandemic has moderately affected the bovine-based collagen for the biomedical applications industry. The rapid spread of COVID-19 has led to several thousands of hospital admissions. The focus of healthcare professionals has been shifted toward the treatment of COVID-19-infected patients, which affected the treatment of non-emergency medical conditions, amid the pandemic.
Based on application, the bovine-based collagen for the biomedical applications market has been classified into bone graft substitutes, cartilage repairs, collagen-based scaffolds, hemostats, skin substitutes, and wound dressings. Under these, the bone graft substitutes held the largest market share in 2020 and are likely to grow at a considered CAGR during the forecast period. A bone graft substitute implant is expected to behave better. The ductile properties of collagen will enable to improve the poor fracture toughness of hydroxyapatites, which further bolsters the segment growth.
By region, the North American market held a significant market share in 2020 and is projected to grow at a healthy CAGR in the coming years. Rising healthcare spending, the strong presence of key players, growing prevalence of bone-related diseases in the region, well-established healthcare infrastructure, and favorable reimbursement & insurance plans, augment the regional market growth during the forecast timeline.
This market research report provides in-depth information on trends, dynamics, revenue opportunities, competitive landscape, and recent developments in the global bovine-based collagen for biomedical applications market. The historic years considered for the study are 2016-2019, the base year is 2020, the estimated year is 2021, and the forecast period is 2022-2026. Following are the critical questions answered in the report-
Key players operating in the bovine-based collagen for biomedical applications market are-
Here is the list of the group of customers that the Bovine-Based Collagen for Biomedical Applications Market hopes to have the greatest opportunity to convert-
Custom Research: Stratview research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry at [email protected].
The report is delivered digitally through our online portal. Buyers receive login credentials from our team to access the report and may update their credentials at any time after the initial login.
Delivery timelines depend on the status of the report:
For the most accurate delivery timeline, please contact us to confirm the current status of the report.
Yes. You may request a complimentary preview of the report through a video conference with our team.
Yes. The scope of the report can be fully customized to align with your specific research objectives and information requirements.
Please contact us at [email protected], and our team will be happy to discuss your requirements and propose a tailored solution.
Yes. Selected sections of the report can be purchased separately based on your requirements. Please contact us at [email protected] to discuss your needs.
Yes, AI can help gather publicly available information, but its outputs are only as reliable as the data it accesses. Stratview Research reports are built using validated data, extensive primary interviews with industry stakeholders, and the expertise of our experienced research team.
Additionally, many critical insights, including market dynamics, competitive intelligence, and industry-specific trends, are not publicly available and therefore cannot be captured through AI alone.
The bovine-based collagen for biomedical applications market is expected to witness an impressive growth of 9.8% CAGR in the coming years.
BBI Solutions (UK), Symatese (France), Rousselot (Belgium), FOODMATE CO., LTD. (China), Botiss biomaterials GmbH (Germany), Medtronic (Ireland), Taxus Cardium (US), KYERON (Neth-erlands), Collagen Matrix, Inc. (US), and Gurnet Point Capital (US) are among the key players in the bovine-based collagen for biomedical applications market.
The bovine-based collagen for biomedical application market size is expected to reach USD 1,184.9 million in the foreseeable future.
The bone graft substitutes held the largest share in the bovine-based collagen for biomedical applications market in 2020.
North America is expected to grow at a healthy CAGR in the bovine-based collagen for biomedical applications market in the next five years.
Bovine-Based Collagen for Biomedical Applications companies, Bovine-Based Collagen for Biomedical Applications distributors, Medical companies, Government organizations are the target audience in the bovine-based collagen for biomedical applications market.
WE ACCEPT
